Siddhartha Goutam

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Epidermal Growth Factor Receptor

Patient Reported Outcomes

Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Siddhartha Goutam, Sunita Ghosh, Jordan Stosky, Alexander Tam, Sarah Quirk, Alysa Fairchild, Jackson Wu, Marc Kerba
An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada. Current oncology (Toronto, Ont.) 30 (12) (2023)
Siddhartha Goutam, Sunita Ghosh, Jordan Stosky, Alexander Tam, Sarah Quirk, Alysa Fairchild, Jackson Wu, Marc Kerba
An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada. Current oncology (Toronto, Ont.) 30 (12) (2023)
Siddhartha Goutam, Sunita Ghosh, Jordan Stosky, Alexander Tam, Sarah Quirk, Alysa Fairchild, Jackson Wu, Marc Kerba
An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada. Current oncology (Toronto, Ont.) 30 (12) (2023)
Siddhartha Goutam, Sunita Ghosh, Jordan Stosky, Alexander Tam, Sarah Quirk, Alysa Fairchild, Jackson Wu, Marc Kerba
An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada. Current oncology (Toronto, Ont.) 30 (12) (2023)
Siddhartha Goutam, Sunita Ghosh, Jordan Stosky, Alexander Tam, Sarah Quirk, Alysa Fairchild, Jackson Wu, Marc Kerba
An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada. Current oncology (Toronto, Ont.) 30 (12) (2023)
Taylor E Woo, Igor Stukalin, Philip Q Ding, Siddhartha Goutam, Michael S Sander, Benjamin W Ewanchuk, Winson Y Cheung, Daniel Y C Heng, Tina Cheng
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current oncology (Toronto, Ont.) 30 (10) (2023)
Siddhartha Goutam, Igor Stukalin, Benjamin Ewanchuk, Michael Sander, Philip Q Ding, Daniel E Meyers, Daniel Heng, Winson Y Cheung, Tina Cheng
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab. Current oncology (Toronto, Ont.) 29 (10) (2022)
Heidi A I Grosjean, Samantha Dolter, Daniel E Meyers, Philip Q Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y C Heng, D Gwyn Bebb, Don G Morris, Winson Y Cheung, Aliyah Pabani
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database. Current oncology (Toronto, Ont.) 28 (5) (2021)